Position in SLDB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$820,179
-$74,579 QoQ
Shares Held
82,100
-33.9% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 155 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLDB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. SLDB ranks #188 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in SLDB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $820,179 | 82,100 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $894,758 | 124,272 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $297,792 | 52,800 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,861,029 | 463,700 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $648,980 | 175,400 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $329,972 | 82,493 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $510,287 | 73,212 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,573,787 | 277,564 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $916,029 | 68,771 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $233,755 | 38,071 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $71,996 | 28,570 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $144,990 | 27,670 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $183,736 | 38,763 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $278,484 | 51,763 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $472,730 | 1,012,270 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $874,061 | 1,418,931 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,522,290 | 1,268,575 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,063,699 | 607,828 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $960,409 | 401,845 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,408,313 | 384,785 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $562,815 | 74,250 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $198,233 | 97,652 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $382,365 | 130,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $206,856 | 86,551 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||